Prevention of multiple whole blood donations by an individual at the same month through the creation of a national Deferred Donor Registry (DDR)

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
BERMUDEZ-FORERO, Maria-Isabel
ANZOLA-SAMUDIO, Diego-Alexander
GARCIA-OTALORA, Michel-Andres
Citação
TRANSFUSION AND APHERESIS SCIENCE, v.62, n.5, article ID 103767, 6p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: The Colombian National Institute of Health administers the National Information System of Haemovigilance (SIHEVI-INS). Today, SIHEVI-INS constitutes a national blood donor and recipient database, which contains a national deferred donor registry (DDR), allowing blood banks to take acceptance or rejection decisions of a potential donor in real time. The study aimed to determine the rate of people who have made more than one whole blood donation monthly in Colombia, violating the national guideline of intervals between donations (three months for men and four for women), since DDR implementation.Methods: We detected the unique personal identification number of people who, in 30 calendar days, made more than one whole blood donation at any of the 83 blood banks set up in Colombia. There were three comparison periods: 01/01/2018-08/31/2019 (launch of SIHEVI-INS and first national feedback); 09/01/2019-12/31/2020 (second feedback) and 01/01/2021-09/30/2022 (massive incorporation of web services).Results: For the first period, blood banks accepted 18.0 donations per 1000 people. There was a rate of 28.8 people/10,000 donations who had donated whole blood twice within 30 days. In the second period, there were 17.0 donations/1000 people and a rate of 2.1 people/10,000 donations (OR:14.0 CI95 %:12.2-16.0). For the last period, there were 18.2 donations/1000 people and a rate of 0.9 individuals/10,000 donations (OR:31.3 CI95 %:26.6-36.9, p < 0.001).Conclusion: DDR reduced by 31 times the acceptance of blood donors who made more than one whole blood donation in the same month. It was necessary to provide periodic feedback and promote web service implementation to reduce this risky behavior.
Palavras-chave
Whole blood, Inter -donation interval, Blood bank, Information systems
Referências
  1. Bednall TC, 2011, TRANSFUS MED REV, V25, P317, DOI 10.1016/j.tmrv.2011.04.005
  2. Beltran M., 2011, Circular 082 de 2011
  3. Benítez J, 2021, BIOMEDICA, V41, P140, DOI 10.7705/biomedica.6003
  4. Bermudez Forero M.I., 2021, Informe Ejecutivo de la Red Nacional Servicios de Transfusion Colombia 2020
  5. Bermudez Forero M.I, 2022, Informe Diagnostico Servicios de Transfusion Colombia 2021
  6. Bermudez Forero MI., 2022, Informe Anual de la Red Nacional Bancos de Sangre Colombia 2021
  7. Bermudez Forero MI., 2021, Informe de Diagnostico de la Red Nacional Bancos de Sangre Colombia 2020
  8. Bermudez Forero MI., 2020, Informe Ejecutivo de la Red Nacional Bancos de Sangre Colombia 2019
  9. Bermudez Forero MI., 2019, Informe Ejecutivo de la Red Nacional Bancos de Sangre Colombia 2018
  10. Browne A, 2020, TRANSFUS MED REV, V34, P10, DOI 10.1016/j.tmrv.2019.10.002
  11. Carmona-Fonseca J, 2022, PATHOGENS, V11, DOI 10.3390/pathogens11080893
  12. Chew E, 2015, ISBT Sci Ser, V10, P31, DOI [10.1111/voxs.12176, DOI 10.1111/VOXS.12176]
  13. Cruz Harold Fabián, 2012, rev.udcaactual.divulg.cient., V15, P19
  14. Cuenta de Alto Costo (CAC), 2021, Fondo Colombiano de Enfermedades de Alto Costo., V1, P145
  15. DANE, 2023, Proyecciones de poblacion 2018-2070. DANE Departamento Administrativo Nacional de Estadistica
  16. Devine DV, 2019, LANCET HAEMATOL, V6, pE492, DOI 10.1016/S2352-3026(19)30162-0
  17. Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1
  18. Domen RE, 1997, INT J QUAL HEALTH C, V9, P35, DOI 10.1093/intqhc/9.1.35
  19. García Gutiérrez Marcela, 2003, Rev Panam Salud Publica, V13, P85
  20. Garcia Otalora M.-A, 2023, Informe de hemovigilancia 2020: Reacciones Adversas a la Donacion (RAD)
  21. Garcia-Otalora M.-A., 2022, Informe de Reacciones adversas a la transfusion 2019
  22. Garcia-Otalora M-A, 2022, Inst Nac De Salud, V1, P102
  23. Garraud O, 2014, BLOOD TRANSFUS-ITALY, V12, pS404, DOI 10.2450/2013.0213-12
  24. Gobierno de Colombia, 2012, Ley 1581 de 2012
  25. Gobierno de Colombia, 2008, Ley 1266 de 2008
  26. Goldman M, 2016, VOX SANG, V110, P185, DOI 10.1111/vox.12323
  27. Herrera G, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006419
  28. Herrera-Hernandez A., 2019, Anexo tecnico 4 circular 082 de 2011
  29. Holland PV, 2008, TRANSFUSION, V48, P6, DOI 10.1111/j.1537-2995.2007.01558.x
  30. International Haemoviglance Network, 2019, Current Members.
  31. ISBT I, 2012, An Effective Tool for Improving Transfusion Safety, V1
  32. Kaptoge S, 2019, LANCET HAEMATOL, V6, pE510, DOI 10.1016/S2352-3026(19)30106-1
  33. Mayorga Mogollon L.E, 2022, Informe de Evento. Hepatitis B, C y Coinfeccion B-D. Periodo epidemiologico XII
  34. Mayorga Mogollon L.E, 2022, VIH SIDA PERIODO EPI
  35. Ministerio de Salud, 1993, Decreto 1571 de 1993.
  36. Ministerio de Salud, Resolucion 1738 de 1995 1995
  37. Ministerio de Salud y Proteccion Social, Resolucion 437 de 2014 2014
  38. Ministerio de Salud y Proteccion Social, 2016, Decreto numero 780 de 2016.
  39. Ministerio de Salud y Proteccion Social, 2018, Resolucion 3212
  40. Mora-Salamanca AF, 2020, INT J INFECT DIS, V97, P81, DOI 10.1016/j.ijid.2020.05.051
  41. PPTA. National Donor Deferral Registry (NDDR), 2023, About us
  42. Ramoa A, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/6183468
  43. Registraduria, Cedula de ciudadania. Cedula de ciudadania.
  44. Schipperus MR, 2019, TRANSFUSION, V59, P2482, DOI 10.1111/trf.15389
  45. Sherwood William C., 1993, Transfusion Medicine Reviews, V7, P121, DOI 10.1016/S0887-7963(93)70131-5
  46. uenta de Alto Costo (CAC), 2021, Fondo Colombiano de Enfermedades de Alto Costo., V1, P86
  47. Urbina A, 2022, TRANSFUS APHER SCI, V61, DOI 10.1016/j.transci.2021.103340
  48. World Health Organization, 2016, A guide to establishing a national haemovigilance system., V1